Differential Effects of Voltage-Dependent Inactivation and Local Anesthetics on Kinetic Phases of Ca2+ Release in Frog Skeletal Muscle  by Brum, Gustavo et al.
Biophysical Journal Volume 85 July 2003 245–254 245
Differential Effects of Voltage-Dependent Inactivation and Local
Anesthetics on Kinetic Phases of Ca21 Release in Frog Skeletal Muscle
Gustavo Brum,* Nazira Piriz,* Rafael DeArmas,* Eduardo Rios,z Michael Stern,§ and Gonzalo Pizarro*y
*Departamento de Biofı´sica, Facultad de Medicina and ySeccio´n Biofı´sica, Facultad de Ciencias, Universidad de la Repu´blica,
Montevideo, Uruguay; zDepartment of Physiology and Molecular Biophysics, Rush University, Chicago, Illinois USA; and
§National Institutes of Health, Bethesda, Maryland USA
ABSTRACT In voltage-clamped frog skeletal muscle ﬁbers, Ca21 release rises rapidly to a peak, then decays to a nearly
steady state. The voltage dependence of the ratio of amplitudes of these two phases (p/s) shows a maximum at low voltages
and declines with further depolarization. The peak phase has been attributed to a component of Ca21 release induced by Ca21,
which is proportionally greater at low voltages. We compared the effects of two interventions that inhibit Ca21 release:
inactivation of voltage sensors, and local anesthetics reputed to block Ca21 release induced by Ca21. Holding the cells partially
depolarized strongly reduced the peak and steady levels of Ca21 release elicited by a test pulse and suppressed the maximum
of the p/s ratio at low voltages. The p/s ratio increased monotonically with test voltage, eventually reaching a value similar to the
maximum found in noninactivated ﬁbers. This implies that the marked peak of Ca21 release is a property of a cooperating
collection of voltage sensors rather than individual ones. Local anesthetics reduced the peak of release ﬂux at every test
voltage, and the steady phase to a lesser degree. At variance with sustained depolarization, they made p/s low at all voltages.
These observations were well-reproduced by the ‘‘couplon’’ model of dual control, which assumes that depolarization and
anesthetics respectively, and selectively, disable its Ca21-dependent or its voltage-operated channels. This duality of effects
and their simulation under such hypotheses are consistent with the operation of a dual, two-stage control of Ca21 release in
muscle, whereby Ca21 released through multiple directly voltage-activated channels builds up at junctions to secondarily open
Ca21-operated channels.
INTRODUCTION
From a phenomenological standpoint, the release of sar-
coplasmic reticulum (SR) Ca21 that triggers contraction in
skeletal muscle is entirely controlled by the transmem-
brane potential in transverse (T) tubules. The time course
of the SR Ca21 permeability upon step depolarization shows
an early peak, then inactivates to a steady level that may
be maintained for hundreds of milliseconds. The mecha-
nism of this fast inactivation is not established. It may be
mediated by Ca21 (Schneider and Simon, 1988; Jong et al.,
1995), but not by voltage, as it is not accompanied by any
change in intramembranous charge movement.
Amphibian and mammalian muscles differ strikingly in
the voltage dependence of the ratio, p/s, between peak and
steady release levels. In the frog, the ratio is generally
greater, and exhibits a distinct maximum at ;10–20 mV
positive to the threshold of Ca21 release detection. In
mammals, however, the maximum is reached asymptotically
at high voltages (Shirokova et al., 1996). The difference has
been ascribed to a component of Ca21 release induced by
Ca21 (CICR, Endo et al., 1970; Endo, 1985) that differs
between the two taxonomic classes.
A reappraisal of the functional signiﬁcance of CICR has
taken place during the last 10 years. This was initially
motivated by the structural ﬁndings of Block et al. (1988) of
a precise arrangement that leaves every other release channel
devoid of T-membrane voltage sensors. A dual control
mechanism was proposed accordingly, where Ca21-gated
and voltage-gated channels respectively contribute peak and
steady components of release ﬂux (Rı´os and Pizarro, 1988).
Functional (Csernoch et al., 1993; Brum and Pizarro, 1998)
and pharmacological data in frog twitch muscle (Pizarro
et al., 1992) generally support the scheme, while studies of
Ca21 sparks have added to the evidence. Because the peak
of Ca21 release appears to reﬂect superposition of many
synchronous sparks, the evidence that sparks are gated by
Ca21 (Klein et al., 1996) upholds the CICR hypothesis.
However, it has also become clear that the steady component
of Ca21 release comprises sparks, making it necessary to
admit a contribution of CICR to its activation as well.
The meaning of the phases of release is clariﬁed by
calculations with a model that gives explicit form to the
hypothesis (Stern et al. 1997), assuming release generators
—couplons—composed of equal numbers of voltage- and
Ca21-operated channels interacting through the local [Ca21].
With this model the peak is largely due to the Ca21-gated
ﬂux, while the steady phase is mixed, largely mediated by
Ca21 at low voltages, and increasingly carried through
voltage-gated channels as voltage increases. Increasing the
weight of CICR in the model (by assuming, for instance,
greater unitary current through its channels) increases the p/s
ratio.
Differences in CICR contribution might therefore explain
the different voltage dependence of p/s in frogs and mammals
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(Shirokova et al., 1996; Stern et al., 1997). The presence of
two isoforms of release channels in amphibia, only one of
which may interact with the voltage sensor (Protasi et al.,
2000), suggests that mechanistic differences between the two
taxonomic classes correspond to differences in molecular
endowment and arrangement. This plausible structural
correlate heightens the relevance of the kinetic features,
including the characteristic voltage dependence of p/s.
In the present study we compare the effects of two
modiﬁers of this ratio: voltage-dependent inactivation, to
affect direct control by the voltage sensors, and local
anesthetics, because they are reputed to block CICR (Pizarro
et al., 1992; Sa¨rko¨zi et al., 1996; in the presence of caffeine,
Klein et al., 1992). The experimental results are then
interpreted through simulations with the couplon model.
METHODS
The experiments were carried out on cut ﬁbers voltage-clamped in a two-
Vaseline gap (Kovacs et al., 1983). Depending on the availability of frog
species, semitendinosus muscles were removed from either Leptodactylus
ocellatus or Rana catesbeiana. The frogs were euthanized by decapitation
under deep ethanol anesthesia. A 2-cm-long piece of ﬁber was dissected
from the muscle and mounted in a three-compartment Lucite chamber where
the double-Vaseline gap was made. Fibers obtained from L. ocellatus were
immobilized by stretching whereas ﬁbers from R. catesbeiana were
immobilized using high intracellular EGTA (see below). Several notches
were made to the regions of the ﬁber in both end compartments to allow
exchange of intracellular solution. The preparation was cooled to temper-
atures between 10 and 158C by means of a Peltier device.
Solutions
The extracellular solution consisted of 130 mM Tetraethylammonium
methylsulfonate (TEA-CH3SO3), 6 mM CaSO4, and 10 mM Tris maleate.
The pH value was titrated to 7 with TEAOH. The intracellular solution
contained 120 mM Cs Glutamate, 10 mM Cs Tris maleate, and 5 mM Mg
ATP. In experiments with stretched ﬁbers, 1 mM ethylene glycol-bis(b-
aminoethyl ether)-N,N,N9,N9-tetraacetic acid (EGTA), and 0.8 mM
antipyrylazo III (APIII; Sigma, St. Louis, MO) were included. In experi-
ments with slack ﬁbers, 8 mM EGTA and 0.25–0.4 mM ﬂuo-3
(pentapotassium or ammonium salt; Molecular Probes, Eugene, OR) were
used instead. Free Ca21was set to 50 nMwith CaCl2, assuming a KD¼ 0.37
mM for EGTA. Dissection and mounting of single ﬁbers were carried out in
a relaxing solution containing 130 mM K Glutamate, 2 mM MgCl2, 5 mM
Tris maleate buffer, and 0.1 mM EGTA. Despite the use of different
techniques for ﬁber immobilization, no differences were observed among
results with the different frog species.
Electronics and data acquisition
The voltage-clamp ampliﬁer was built according to a design of Francini and
Stefani (1989). Data acquisition was performed with a 16-bit resolution,
200-kHz board (HSDAS-16; Analogic Corporation, Wakeﬁeld, MA).
Sampling rates ranged between 3 and 20 kHz per channel. Data were
ﬁltered before acquisition by a one–pole passive ﬁlter with 0.3-kHz cutoff
frequency. Command pulses were generated with the D/A channels of the
HSDAS board. Membrane currents, membrane voltage, and the change in
transmitted or emitted light were measured simultaneously during ﬁber
activation by clamp pulses.
Optical measurements and processing of the
optical signals
Optical signals were recorded as described by De Armas et al. (1998).
Brieﬂy, in light absorption experiments (using APIII) a slit of light of l[
600 nm was imaged on the ﬁber. The transmitted light, collected by a water
immersion objective (numerical aperture 0.75, 403; Zeiss Oberkochen,
Germany), was split into two beams, of wavelengths$800 nm. These were
further ﬁltered and measured with photodiodes. The signal at 720 nm
contained an APIII-related absorbance change together with a change in
intrinsic ﬁber absorbance. The latter was measured in isolation at l[ 800
nm, then scaled and subtracted to yield the APIII-related signal. The latter
was processed (Kovacs et al., 1983) to derive the change in myoplasmic
Ca21 concentration. In ﬂuorescence experiments, ﬂuo-3 was excited by epi-
illumination at 490 nm, through an interference ﬁlter placed between
a halogen light source and a 510-nm high-pass dichroic mirror. The emitted
light was ﬁltered at 530 nm by a second interference ﬁlter and recorded by
a high sensitivity photodiode (HUV-200; EG&G, Quebec, Canada). The
Ca21 transient was derived as described by Shirokova et al. (1996), with koff
¼ 80 s1 and kon ¼ 90 s1 mM1 as rate constants of ﬂuo-3 and extinction
coefﬁcients of ﬂuo-3 measured in our optical apparatus (e490¼ 5.44 3 104
M1 cm1, e530¼ 0.973 104 M1 cm1). Concentrations of both dyes were
determined from light path and absorbance measurements made at regular
intervals during the experiment; at 550 nm for APIII (e550¼ 2.443 104 M1
cm1) and at 510 nm for ﬂuo-3 (e510 ¼ 6.95 3 104 M1 cm1).
SR Ca21 release ﬂux was derived from the Ca21 transient using the
procedure of Melzer et al. (1984) modiﬁed by Brum et al. (1988). Brieﬂy,
release ﬂux was calculated as the sum of the rate of increase of free [Ca21]
and the rate of extrusion by an explicit removal model, ﬁtted to the decay
of a set of Ca21 transients elicited by pulses of various amplitudes and
duration. The removal model included Ca21 buffers in the myoplasm, plus
those added to the internal solution (i.e., EGTA, APIII, ﬂuo-3). Some of the
parameters characterizing the Ca21 binding sites were adjusted in the ﬁt.
Values of parameters for the signiﬁcant buffers are given in the ﬁgure
legends.
The waveform obtained this way, termed Ca21 release ﬂux, was
corrected for SR Ca21 depletion as described by Schneider et al. (1987). The
correction procedure assumes that the SR Ca21 permeability attains a steady
level after 100–200 ms of depolarization, and thereafter the ﬂux is simply
proportional to the total [Ca] in the SR (CaSR), as stated in Eq. 1,
Ca release fluxðtÞ ¼ r3 SR permeabilityðtÞ3CaSRðtÞ;
(1)
with
CaSRðtÞ ¼ CaSRð0Þ 
ð t
0
Ca release fluxðtÞdt; (2)
where r is the surface-to-volume ratio of the SR; CaSR(0) is the initial [Ca ]
in the SR (expressed as Ca content of the SR per unit volume of myoplasmic
water); and the running integral of the ﬂux is the change in SR [Ca], again
per unit volume of myoplasm. The release ﬂux was divided point-by-point
by the difference in Eq. 2, yielding a record proportional to the time course
of the SR Ca21 permeability (with units of ms1). CaSR(0) was adjusted,
if necessary, to achieve a steady late phase of release after every new
intervention, but in most cases these adjustments were not signiﬁcant.
Pooled data for each intervention gave differences in SR content (before and
after intervention) that were not signiﬁcantly different.
Intramembranous charge movement
Charge movement currents were recorded as described previously (De
Armas et al., 1998). Brieﬂy, asymmetric currents were obtained as difference
between the current during the test pulses and the voltage-scaled current
246 Brum et al.
Biophysical Journal 85(1) 245–254
measured during control pulses. Current transients were then obtained by
subtraction of sloping baselines separately ﬁtted to ON and OFF portions.
When the ﬁber was normally polarized, control pulses were to 100 mV
from a subtracting holding potential of 120 mV. Alternatively in
depolarized ﬁbers, the control pulses were positive from a holding potential
(HP) of 0 mV. Charge displacements QON and QOFF were obtained by
integration of the corresponding transients. In the brief repriming experi-
ments in which charge movement was studied, the controls obtained in the
depolarized condition were used also to analyze the charge movement after
polarization to a negative HP.
Plots of Ca21 release or charge movement versus voltage were ﬁtted to
a two-state Boltzmann function (Eq. 3) by a least-squares routine,
XðVÞ ¼ Xmax
11 expððV  VÞ=kÞ ; (3)
where V* is the central voltage of the distribution, k the slope at the inﬂexion
point, and Xmax the limiting value at high positive voltages.
Statistical signiﬁcance was determined by the two-tailed Student’s t-test
at the level of p ¼ 0.05.
Simulations
These were carried out using the couplon model (Stern et al., 1997) with
parameter values listed therein. Macroscopic release waveforms were
generated adding 1000 Monte Carlo realizations of the model. The
synthesized waveforms were treated in the same way as the experimental
ones, deriving a permeability time course by the depletion correction
procedure described in the preceding paragraph.
RESULTS
Inactivating holding potentials changed the
voltage dependence of p/s, but not its maximum
Skeletal muscle excitation-contraction coupling is known to
undergo a voltage-dependent inactivation process (Hodgkin
and Horowicz, 1960). Less polarized holding potentials
progressively inhibit Ca21 release, as they reduce the
availability of charge movement (e.g., see Rı´os and Pizarro,
1991).
The effect of such intervention on permeability wave-
forms in a ﬁber from R. catesbeiana is shown in Fig. 1. The
experiment consisted in the determination of kinetics of
Ca21 release, as a function of voltage, in three conditions: 1),
reference; 2), partial inactivation at a depolarized HP; and 3),
partial recovery after inactivation.
To explore condition 3, the ﬁber was ﬁrst held at 0 mV. A
partial recovery (‘‘repriming’’) interval of 2 s at 100 mV
was applied, followed by test pulses to different potentials
(Fig. 1 A). Next, to obtain the (reference) voltage dependence
of release the ﬁber was polarized to 90 mV and allowed to
recover fully (Fig. 1 B). Finally, for condition 2 the HP was
set to70 mV and the same test voltages were explored (Fig.
1 C). Upon partial inactivation, peak and steady permeability
were markedly reduced (Fig. 1 D). The biggest reduction
was found with the brief repriming protocol.
In reference condition, the p/s ratio had a maximum at
;15 mV positive to the threshold for Ca21 release. The
partial inactivation or repriming protocols changed this
voltage dependence, making it monotonically increasing
(Fig. 1 E). Values for p/s were greater upon partial in-
activation or repriming than in reference at intermediate and
high test voltages. Similar results with depolarizedHP (in the
range between –70 and –60 mV) were obtained in seven
ﬁbers (averages in Fig. 5 A). To make different ﬁbers
comparable, the individual curves were shifted by Vmax, the
voltage corresponding to the maximum value of the ratio.
The maximum p/s in partially depolarized ﬁbers was not
statistically different from that in the fully polarized ﬁbers.
However, it occurred at low to intermediate voltages in the
FIGURE 1 Effect of depolarized HP on release ﬂux permeability
components and their ratio. (A) Corrected release records taken while the
ﬁber was held at 0 mV and a prepulse to 100 mV for 2 s before the test
pulse was applied. (B) Records taken after full repriming at –90 mV. (C)
Effect of changing HP from 90 to 70 mV. Fiber 4088, from R.
catesbeiana; [ﬂuo-3] ranged from 121 to 290 mM. Time elapsed was 28 min.
Initial Ca content of the SR was 800 mM in all cases. Parameters of removal,
[EGTA] ¼ 4.5 mM; koffEGTA ¼ 2.4 mM1 s1; and konEGTA ¼ 3.2 s1. (D)
Voltage dependence of peak and steady permeability. (E) The p/s ratio. In D
and E,HP¼90 mV (black symbols).HP¼70 mV (gray symbols). Brief
repriming protocol (unﬁlled symbols). InD, peak (circles); and steady values
of permeability (triangles). Best-ﬁt of a two-states Boltzmann function to the
data points (continuous lines). Parameters of the Boltzmann ﬁt, PSRmax ¼
13.94 3 103 ms1, V* ¼ 40.18 mV, and k ¼ 4.74 mV for the peak
permeability; PSRmax ¼ 6.273 103 ms1, V* ¼ 33.07 mV, and k ¼ 6.28
mV for the steady SR permeability at Vh¼90 mV; PSRmax¼ 5.093 103
ms1, V*¼ 26 mV, and k ¼ 7.93 mV for the peak permeability; PSRmax ¼
1.16 3 103 ms1, V* ¼ 24.99 mV, and k ¼ 9.7 mV for the steady SR
permeability at Vh ¼ 70 mV; PSRmax ¼ 4.37 3 103 ms1, V* ¼ 14.06
mV, and k¼ 7.38 mV; and PSRmax ¼ 5.893 104 ms1, V*¼22.21 mV,
and k ¼ 6.13 mV for the brief repriming protocol.
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polarized ﬁber, and in an extended, more positive range after
partial inactivation. Fig. 5 B shows average results for the
brief repriming protocol.
The positive shift of the ratio as well as the loss of its local
maximum were associated with a shift in the same direction
of the voltage dependence of peak and steady release ac-
tivation. Also a reduction in the slope of Boltzmann ﬁts was
found (with parameters given in the legend of Fig. 5). All
these changes were greater for the brief repriming situation,
even more noticeable than the reduction of the amplitude of
SR permeability itself. In principle, this may have been due
to inactivation of the voltage sensor, perhaps accompanied
by changes in voltage dependence of its activation. The
possibility was tested in the experiments illustrated in Fig. 2.
The movement of intramembranous charge in ﬁbers
inactivated by depolarization, which occurs at potentials
\50 mV, is attributed to transitions between inactivated
states of the voltage sensors (Brum and Rı´os, 1987; Brum
et al., 1988; Rı´os and Pizarro 1991; Shirokov et al., 1998).
To emphasize the difference with the polarized situation and
the fact that its movement does not gate channels, the charge
mobile in depolarized ﬁbers is called ‘‘charge 2.’’ If the
holding voltage is made more negative, some recovery, or
‘‘repriming’’ occurs, and the overall charge distribution is
shifted to more positive voltages. This is interpreted as
partial conversion of charge 2 to charge 1, which moves
positive to –70 mV and gates Ca21 release. The slight
superposition of the distributions of charge 1 and charge 2
required a special procedure to quantify charge 1 in the
substantially inactivated ﬁbers, particularly after the brief
repriming protocol. The distribution measured in the
partially recovered condition was ﬁtted with the sum of
two Boltzmann functions, one of which had the voltage
dependence of charge 2, ﬁrst determined in the fully
inactivated ﬁber held at 0 mV. The difference between total
charge transfer and charge 2 (calculated from the ﬁt) is
plotted against test voltage in Fig. 2 A.
The analysis is rather indirect and susceptible to errors,
associated with changes in linear electrical properties upon
prolonged changes in holding potentials. Even allowing for
such errors, shifts in the voltage dependence of charge 1
were comparatively minor, and certainly insufﬁcient to
explain the consistent right shift of release activation shown
in Fig. 2 B. The voltage dependence of the p/s ratio
calculated for this set of ﬁbers in the two conditions is plotted
in Fig. 2 C.
Procaine and tetracaine changed the
peak/steady release ratio
The local anesthetics procaine and tetracaine are known
inhibitors of excitation-contraction coupling in frog skele-
tal muscle (Donaldson, 1989; Endo, 1985). Here the drugs
were applied extracellularly to stretched and slack ﬁbers, at
concentrations that did not suppress charge movement.
Application of either drug reversibly reduced the Ca21
transients and the underlying Ca21 release ﬂux at every test
voltage. Procaine required a higher extracellular concentra-
tion, consistent with its lower membrane permeability at
physiological pH (Hille, 1977; Sa´nchez and Caputo, 1987)
and its lower efﬁcacy (Xu et al., 1993).
The effect of procaine (1 mM) at various test voltages in
a stretched ﬁber of L. ocellatus is illustrated in Fig. 3.
FIGURE 2 Effect of partial inactivation on the distribution of trans-
membrane mobile charge. The voltage dependence of charge movement and
Ca21 release ﬂux was studied in fully reprimed condition at HP ¼ 90 mV
(solid circles) and after partial repriming produced by a conditioning pulse
of 2 s to 100 mV from HP ¼ 0 (unﬁlled circles) in three ﬁbers of the four
used in Fig. 5. To compare different ﬁbers, data from each ﬁber were shifted
by the value of V* ﬁtted to the charge distribution in the fully primed
condition (Average V* ¼ 22.2 6 5.8 mV). (A) Charge 1, estimated as
explained in the text, and normalized to the maximum value measured in
each condition, is plotted vs. test voltage.Qmax atHP¼90 mVwas 33.66
3.6 nC/mF. Brief repriming protocol, 14.0 6 3.1 nC/mF. Parameters of the
ﬁt, HP ¼ 90 mV, Qmax¼ 1.00, k ¼ 13.75 mV, and V* ¼ 0.70 mV. Brief
repriming protocol, Qmax¼ 1.02, k ¼ 15.55 mV, and V* ¼ 4.14 mV. (B)
Normalized peak release ﬂux, PSRmax atHP¼90 mV was 23.26 3.8 mM/
ms1. Brief repriming protocol, 8.0 6 1.4 mM/ms1. Parameters of the ﬁt,
HP ¼ 90 mV, PSRmax ¼ 0.96, k ¼ 7.01 mV, and V* ¼ 2.26 mV. Brief
repriming protocol, PSRmax ¼ 0.99, k ¼ 11.33 mV, and V* ¼ 16.11 mV.
[Ca]SR used for correction varied from 1600 to 2500 mM. (C) Peak/steady
permeability ratios.
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Whereas the permeability peak was reduced at every test
voltage, the steady level was affected more at higher test
voltages. Peak and steady permeabilities as well as their ratio
are plotted at bottom (Fig. 3, C and D).
The effects of procaine on peak and steady levels of SR
permeability, which depend on test voltage, are summarized
for four experiments in Fig. 5 C. As mentioned above, the
effect on the steady level became signiﬁcant only at the more
depolarized voltages. The p/s ratio is also plotted in Fig. 5 C
(right). As in Fig. 5, A and B, the abscissa was shifted by
Vmax (established in records obtained before the application
of procaine). The drug abolished the maximum, making the
ratio almost voltage-independent. Despite an almost 50%
reduction in permeability, the ratio at positive test voltages
was not signiﬁcantly changed. The reversibility of the effect
after washout of the drug was tested for large voltage pulses.
The peak recovered to 97 6 16% of its reference amplitude
at 0 mV, whereas the steady component recovered to 105 6
8%. The ratio obtained corresponded to 926 11% (n¼ 4) of
the value computed in reference.
20 mM tetracaine had qualitatively similar effects, as
shown in Fig. 4, where the reversibility of the effect is also
documented. Average effects on seven ﬁbers are represented
in Fig. 5 D. While not seen in the experiment of Fig. 4 D,
FIGURE 3 Effect of 1 mM procaine on kinetic terms of Ca21 release
permeability and their ratio. (A) Corrected release records obtained in
a stretched L. ocellatus with 1 mM EGTA in the internal solution. (B)
Release records at the same voltages after 1 mM procaine. Fiber 412. [APIII]
ranged from 0.75 to 1.11 mM; time elapsed was 21 min. Initial Ca content of
the SR was 1600 mM both in reference and in procaine. Parameters of
removal, [EGTA]¼ 1.08 mM, koffEGTA¼ 3 mM1 s1, konEGTA¼ 2.46 s1,
maximum pump rate ¼ 0.46 mM1 s1, and [Parvalbumin] ¼ 2.96 mM, 50
nM free Ca21. (C) Voltage dependence of both kinetic components of
corrected release waveforms. The black symbols correspond to the reference
values (peak permeability, circles; steady permeability, triangles), and the
unﬁlled symbols are in the presence of 1 mM procaine. One-Boltzmann
function ﬁts to the data points (continuous lines). Parameters of the
Boltzmann ﬁt to the averages, PSRmax ¼ 20.02 3 103 ms1, V* ¼ 36.36
mV, and k ¼ 10.18 mV for the peak permeability in reference; PSRmax ¼
10.473 103 ms1, V*¼22.77 mV, and k¼ 11.45 mV for the steady SR
permeability in reference; PSRmax¼ 12.423 103 ms1, V* ¼ 34.95 mV,
and k¼ 8.83 mV; and PSRmax¼ 4.573 103 ms1, V*¼ 34.7 mV, and k¼
7.2 mV for the same quantities in 1 mM procaine. (D) Ratios of peak/steady
permeability. Solid symbols are in reference; and unﬁlled symbols in 1 mM
procaine.
FIGURE 4 Effect of 20 mM tetracaine on both kinetic components of
Ca21 release ﬂux and their ratio. (A) Corrected release waveforms obtained
in a ﬁber held at 90 mV with an internal solution containing 5 mM EGTA.
(B) Records obtained after the application of 20 mM tetracaine to the center
pool at the same test voltages. (C) Records obtained after washout of the
drug. Note that all three sets of records are shown with the same scale. Fiber
4191, R. catesbeiana. [Fluo-3] ranged from 95 to 121 mM; time elapsed was
28 min. Initial Ca content of the SR was 2200 mM in all cases. Parameters of
removal, [EGTA] ¼ 5 mM, koffEGTA ¼ 2 mM1 s1, and konEGTA ¼ 5 s1.
(D) Voltage dependence of peak and steady permeability. Reference (black
symbols), tetracaine (unﬁlled symbols), and washout (gray solid symbols).
Peak (circles), steady values of permeability (down-triangles), and best-ﬁt of
a two-states Boltzmann function to the data points (continuous lines).
Parameters of the Boltzmann ﬁt, PSRmax ¼ 10.223 103 ms1, V* ¼ 29.41
mV, and k ¼ 6.55 mV for the peak permeability; PSRmax ¼ 3.59 3 103
ms1, V*¼28.01 mV, and k¼ 7.24 mV for the steady SR permeability in
reference; PSRmax ¼ 9.24 3 103 ms1, V* ¼ 32.15 mV, and k ¼ 6.41 mV
for the peak permeability; PSRmax ¼ 3.94 3 103 ms1, V* ¼ 28.09 mV,
and k ¼ 6.86 mV for the steady SR permeability in washout; PSRmax ¼ 6.89
3 103 ms1, V* ¼ 31.49 mV, and k ¼ 4.91 mV; and PSRmax ¼ 4.1 3
103 ms1, V* ¼ 28.66 mV, and k ¼ 6.21 mV for the same quantities in 20
mM tetracaine. (E) Peak/steady ratio. Same color code as in D.
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a reduction of the steady level at higher voltages became
apparent in the averages. In this particular set of experiments
we found a signiﬁcant reduction of the p/s ratio at every
test voltage. Despite this quantitative difference, both lo-
cal anesthetics abolished the maximum and made the ratio
essentially voltage-independent.
DISCUSSION
In amphibian muscle, two classes of Ca21 release channels
are present in similar densities, comprising four identical
protomers of either of two ryanodine receptor isoforms.
Even inmammalian muscle, where isoform 1 vastly predomi-
nates, two structurally different groups of channels can
be distinguished, on the basis of their relationship with the
T-membrane voltage sensors. Whether this structural dual-
ity has a functional correlate, i.e., multiplicity of release
mechanisms, is controversial. One possibility is that all
channels are controlled—via the DHPr—by membrane
voltage. Alternatively, a second form of release could exist,
dependent on an initial increase in [Ca21] on the cytoplasmic
side of all, or some, of the channels. This second form is
customarily termed CICR.
Two interventions modiﬁed Ca21
release differently
Two interventions were devised in the present work to
interfere with each component speciﬁcally. Depolarization
patterns were designed to partially inactivate voltage sensors,
through steady partial depolarization or long lasting periods
at 0 mV followed by brief recovery. Given their effect on
transmembrane mobile charge, such patterns should reduce
the availability of voltage sensors and interfere with release
activation.
The second intervention, local anesthetics, is expected to
selectively affect release beyond the voltage-sensing stage,
based on the ability of the drugs to interact directly with
release channels reconstituted in bilayers (Xu et al., 1993).
Moreover, the anesthetics should interfere with Ca21-
mediated activation, based on their effects on the [Ca21]
dependence of channel opening in bilayer-reconstituted
systems (Xu et al., 1993), skinned ﬁbers (Donaldson,
1989; Endo, 1985) and vesicular fractions. While local
anesthetics are known to also affect voltage sensor function
in whole ﬁbers (Sa´nchez and Caputo 1987, Hui and Chen,
FIGURE 5 Effect of three interventions on peak and steady components
of Ca21 release ﬂux permeability and their ratio. (A) Depolarized holding
potential. Left, Data points (mean 6 SE) in seven slack ﬁbers from R.
catesbeiana. Peak permeability values (circles) in reference (solid ) or at
depolarized HP (unﬁlled). Corresponding steady values (triangles). Curves
traced with Eq. 3 ﬁtted to the averaged data. Fit parameters, PSRmax ¼ 13.17
3 103 ms1, V*¼ 27.6 mV, and k ¼ 7.89 mV for the peak permeability in
reference; PSRmax¼ 5.333 103 ms1, V*¼25.35 mV, and k¼ 7.09 mV
for the steady SR permeability in reference; PSRmax ¼ 4.83 103 ms1, V*
¼ 33.63 mV, and k ¼ 7.25 mV; and PSRmax ¼ 1.54 3 103 ms1, V* ¼
16.82 mV, and k ¼ 11.63 mV for the depolarized HP. Right, Peak/steady
ratio in reference (solid ) or at depolarizedHP (unﬁlled ). Test voltages in the
abscissa are shifted by the value at which the maximum was observed in
each ﬁber (Vtest Vmax). (B) Brief repriming. Left, Data points (mean6 SE)
obtained in four slack ﬁbers from R. catesbeiana. Peak permeability values
(circles) in reference ( ﬁlled ) or at depolarizedHP (unﬁlled ). Corresponding
steady values (triangles). Fit parameters, PSRmax¼ 11.63 103 ms1, V*¼
26.1 mV, and k ¼ 5.54 mV for the peak permeability in reference; PSRmax
¼ 4.503 103 ms1, V*¼22.65 mV, and k¼ 6.63 mV for the steady SR
permeability in reference; PSRmax ¼ 4.35 3 103 ms1, V* ¼ 8.18 mV,
and k¼ 12.36 mV; and PSRmax¼ 0.923 103 ms1, V*¼17.47 mV, and
k ¼ 11.54 mV for the brief repriming protocol. Right, Peak/steady ratio in
reference (solid) or after brief repriming (unﬁlled). (C) Procaine. (Left) Data
points (mean6 SE) obtained in four stretched ﬁbers from L. ocellatus. Peak
permeability values (circles) in reference ( ﬁlled ) or 1 mM procaine
(unﬁlled). Corresponding steady values (triangles). Fit parameters, PSRmax
¼ 15.3 3 103 ms1, V* ¼ 28.82 mV, and k ¼ 12.72 mV for the peak
permeability in reference; PSRmax ¼ 6.87 3 103 ms1, V* ¼ 16.47 mV,
and k ¼ 12.69 mV for the steady SR permeability in reference; PSRmax ¼
9.03 3 103 ms1, V* ¼ 32.69 mV, and k ¼ 10.26 mV; and PSRmax ¼
3.233 103 ms1, V*¼30.18 mV, and k¼ 10.48 mV in 1 mM procaine.
Right, Peak/steady ratio in reference (solid ) or procaine (unﬁlled ). (D)
Tetracaine. Left, Averages (mean 6 SE) from six slack ﬁbers from R.
catesbeiana with same internal solution as in A. Peak permeability values
(circles) in reference (solid ) or 20 mM tetracaine (unﬁlled ). Corresponding
steady values (triangles). Fit parameters, PSRmax ¼ 13.07 3 103 ms1, V*
¼ 36.74 mV, and k ¼ 6.51 mV for the peak permeability in reference;
PSRmax ¼ 5.64 3 103 ms1, V* ¼ 33.52 mV, and k ¼ 6.88 mV for the
steady SR permeability in reference; PSRmax ¼ 7.56 3 103 ms1, V* ¼
36.51 mV, and k ¼ 7.7 mV; and PSRmax ¼ 3.49 3 103 ms1, V* ¼
35.29 mV, and k ¼ 7.8 mV for the same quantities in 20 mM tetracaine.
Right, peak/steady ratio in reference (solid) or tetracaine (unﬁlled ). In all
graphs, points from proximate voltages (10-mV intervals) were averaged
and ascribed to the mean voltage. Internal solutions had 5 mM EGTA in A,
B, and D, and 1 mM in C. Nominal [Ca21] was 50 nM.
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1992; Csernoch et al., 1988), such effects appear at higher
concentrations than used here.
While both anesthetics determined a sharp reduction in the
p/s ratio (bringing the release waveform to a shape similar to
that of mammalian muscle, compare to Shirokova et al.,
1996), the effect of partial depolarization—leading to in-
activation of voltage sensors—was very different. It sup-
pressed the peak of release at lower activation voltages, but
the waveform of release and its high p/s ratio fully recovered
when greater activation pulses were applied.
The ability of these two kinds of interventions to modify
release ﬂux differently is consistent with the hypothesis of
dual control. To quantitatively test these ideas, a speciﬁc
formalization of dual control is applied in the next section.
A dual control model reproduces the
experimental ﬁndings
The experimental results were confronted with simulations
using the couplon model (Stern et al., 1997), in which release
is produced by interacting channels, separately gated by
voltage or Ca21. The model is based on evidence (Block
et al., 1988) that every other Ca21 release channel in the
junctional double row faces a voltage sensor (tetrad of DHP
receptors) across the triadic gap. It assumes that such
channels (named ‘‘V’’), are voltage-gated, while the others
(named ‘‘C’’), are gated by Ca21. In simulations with this
model, the peak component of release at lower voltages
ﬂows largely through the Ca21-operated channels.
In keeping with the interventions applied here, we
explored whether the effects of depolarization and local
anesthetics would be reproduced by selectively suppressing
C- or V-channels in the model.
No attempt was made to ﬁt the parameters of the model to
our experimental data. The simulation of ‘‘whole cell’’
records involved averaging 1000 realizations of a Monte
Carlo run in a couplon of ﬁxed size, usually 14 C- and 14
V-channels. A fraction F of channels in either class was
disabled as follows. In each realization and for every channel
in the couplon, a random number between 0 and 1 was
compared with F, and the channel was disabled every time
the random number was less than F. This resulted in
a variable fraction of disabled channels at random positions
in each realization, which averaged to F. Channels made
unavailable (representing block by local anesthetics or
inactivation by voltage) remained so throughout the re-
alization. This is justiﬁed for V-channels, as recovery from
voltage-dependent inactivation takes seconds. In regard to
C-channels, tetracaine induces long-lasting closed states of
200 ms in Ryr 1 in bilayers (Xu et al., 1993), and similar
observations were made for procaine acting on Ryr 2
(Zahradnikova and Palade, 1993). This implementation of
V-channel inactivation assumes that all four sensors
associated with a given channel undergo concerted in-
activation. This feature, chosen for computational conve-
nience, may not be an actual property of the inactivation of
the voltage sensors. The channels that remained available
were assumed normal in every sense, including conductance.
The assumption is based on the effects of tetracaine in
bilayers, which at 500 mM reduced the single channel current
by 20%, probably by fast open channel blockade. Assuming
one-to-one stoichiometry of block, 20 mM tetracaine should
reduce single channel current by 1%.
Fig. 6 illustrates the outcome of simulations carried out
with varying fractions of C- or V-channels disabled to explore
the effects on release and p/s ratio. Fig. 6, A–C, shows
representative simulated release current records for the
reference condition (Fig. 6A), voltage-dependent inactivation
(Fig. 6 B), and local anesthetic block (Fig. 6 C). The effect of
suppressing C-channels on the release components or the p/s
ratio is shown respectively in Fig. 6, Da and Db. Simulations
with F¼ 0.3 (10 C-channels available out of 14) or 0.5 (seven
C-channels available) are compared with reference simu-
lations, F ¼ 0, similar to previously published ones (Stern
et al., 1997). This degree of block of C-channels reproduced
well the effects of tetracaine or procaine. One exception was
the steady component of release, experimentally reduced in
most ﬁbers, but not in the simulations. An unspeciﬁc block of
release channels by local anesthetics, as discussed below,
could explain the discrepancy.
In the simulations of Stern et al. (1997) the maximum of
p/s achieved at low voltages depended on the length or num-
ber of channels of the couplon. The ascending limb of the
voltage dependence at constant couplon length reﬂected the
synchronization of triggering of C-channels that follows
faster activation of the voltage-gated ones. Inhibition of
C-channels in the model results in a condition similar to
the short couplons of Stern et al. (1997). Thus the effect of lo-
cal anesthetics, based on this interpretation, would be equiva-
lent to splitting the couplons in operatively shorter units.
Curves in Fig. 6 E were generated after disabling
V-channels. At F ¼ 0.7 or 0.93, the voltage dependence of
p/s became similar to that obtained experimentally in ﬁbers
inactivated by voltage (as shown in Figs. 1, 2, and 5). The
extent of the assumed inactivation had an effect on the
simulated p/s ratio similar to that of increasing inactivation
experimentally. Namely, with greater inactivation the de-
pendence shifted to more positive voltages and, somewhat
surprisingly, the value of the ratio attained at the most
positive test potentials increased above reference values,
both experimentally and in the simulations.
Despite the success in reproducing the experimental p/s
there are relevant differences between the outcome of the
simulations and the experimental voltage dependence of the
inactivated release. While the experiments show a right shift
of the midvoltage and a less steep voltage dependence, only
the ﬁrst ﬁnding is reproduced by the model (see parameters of
Boltzmann ﬁts in legend of Fig. 6). Simulations also had
to assume a more substantial difference in the degree of
inactivation to reproduce the differences in p/s between
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brieﬂy reprimed and partially inactivated (Vh ¼ 70 mV)
ﬁbers.
We do not have deﬁnitive explanations for these differ-
ences. They might reﬂect the contribution of Qg to the
voltage dependence of release activation in reference
conditions, a feature not included in the model. The absence
of Qg may also explain the broader voltage dependence of
p/s in the simulations. Alternatively, the different slope
might be due to the concerted inactivation mechanism as-
sumed in the simulations. Finally, with regard to the larger in-
activation required toreproduce theexperimentalobservations
in the brieﬂy reprimed ﬁbers, the small releases recorded in
these conditions could induce an underestimation of the SR
Ca content which may result in an overestimated SR per-
meability.
As stated in the Introduction, there is no direct
correspondence in the simulation between phases of release
ﬂux and components going through C- or V-channels. To
better understand the processes within the model, we looked
at the relative contributions of each channel class separately
(data not shown). The p/s of the C-component studied in
isolation shows a monotonically increasing voltage de-
pendence. At low voltage this component dominates the total
release current, endowing it with a high p/s ratio. At higher
voltages the V-component becomes signiﬁcant, determining
a reduction in the p/s ratio. When C- or V-channels are
selectively blocked, the voltage dependence of the p/s ratio
curve changes, largely depending on the resulting relative
weight of the release components. Most importantly, when
V-channels are suppressed, the monotonically increasing
ratio of the C-current becomes a property of the total release
current, thus explaining the large value of the p/s ratio
attained at positive voltages.
It is also worth noting that the magnitude of C-release
activation only depends on membrane voltage through its
relationship with activation of V-channels.
The previous simulations assumed a speciﬁc block of
a fraction of C-channels. We have considered other
possibilities, including nonspeciﬁc block of both release
channels, as well as reduction in the single channel current.
Suppressing equal number of C- and V-channels eliminates
the maximum at low voltages of the p/s ratio, producing
an almost ﬂat voltage dependence of this variable, qualita-
tively similar to that obtained after speciﬁc suppression of
C-channels. Alternatively, a reduction of the single channel
current to 50% of its reference value reproduced the p/s
voltage dependence obtained with 50% block of both
channel types. Thus, based on the present simulations, the
observed experimental effects of the local anesthetics do not
have a unique interpretation. On the other hand, the
monotonically increasing p/s ratio observed experimentally
upon voltage-dependent inactivation was reproduced in the
model simulations only through V-channel suppression.
The reduction in p/s ratio by the anesthetics could
alternatively be explained as a consequence of a diminished
FIGURE 6 Simulations; selective blockade of V- and C-channels. Top,
Simulated release currents corrected for depletion for three conditions. (A)
Reference, 14 channel couplon, with all C- and V-channels available. (B)
Block of V-channels; 4 V-channels and 14 C-channels available. (C) Block
of C-channels; 10 C-channels and 14 V-channels available. (D) a, Peak and
steady release currents for all (circles), 10 (triangles), or seven (squares) C-
channels available. The larger plot in each pair corresponding to the three
conditions represents peak currents (unﬁlled symbols), the smaller steady
currents (solid symbols). Fit parameters for 14C and 14V: maximum release
current (MRC) ¼ 3.36 pA/couplon, V* ¼ 24.7 mV, and k ¼ 14.05 mV for
the peak current, MRC ¼ 1.23 pA/couplon, V* ¼ 21.3 mV, and k ¼ 13.4
mV for the steady current. Fit parameters for 10C and 14V:MRC¼ 2.64 pA/
couplon, V*¼ 16.2 mV, and k ¼ 13.6 mV for the peak current; MRC ¼
1.15 pA/couplon, V* ¼ 17.6 mV, and k ¼ 11.9 mV for the steady current.
Fit parameters for 7C and 14V: MRC ¼ 2.04 pA/couplon, V* ¼ 12.2 mV,
k ¼ 12.5 mV for the peak, and MRC ¼ 1.08 pA/couplon, V* ¼ 14.7 mV,
and k ¼ 11.3 mV for the steady current. b, Simulated voltage dependence of
peak/steady ratio, with the same symbol code. (E) a, Peak and steady release
currents for all (circles), four (triangles), or one V-channel available
(squares). Fit parameters for 14C and 14V: same as inD a. For ﬁt parameters
14C and 4V: MRC ¼ 2.56 pA/couplon, V* ¼ 17.2 mV, and k ¼ 13.4 mV
for the peak current; andMRC¼ 0.60 pA/couplon, V*¼23.0 mV, and k¼
14.7 mV for the steady current. Fit parameters for 14C and 1V:MRC¼ 1.30
pA/couplon, V* ¼ 11.8 mV, and k ¼ 13.6 mV for the peak current; and
MRC ¼ 0.29 pA/couplon, V* ¼ 22.9 mV, and k ¼ 15.7 mV for the steady
current. b, Peak/steady voltage dependence calculated from the values in
a (same symbol code). Simulations were carried out with parameter values
of Stern et al. (1997).
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inactivation by Ca21, secondary to the general reduction
in release ﬂux. As shown in Figs. 1 and 5, however, the
reduction of release ﬂux attained through voltage-dependent
inactivation was signiﬁcantly greater than that produced by
any of the drugs. This excludes a reduction in Ca21-
dependent inactivation as explanation for the drug effects.
Furthermore, this feature adds to the evidence that the fast
inactivation process does not depend on bulk Ca21 (Pizarro
et al., 1997).
Comparisons with earlier work and implications
for release control
The ability of voltage-dependent inactivation to alter the
kinetics of Ca21 release supports analysis of the latter into
two separately gated components. It also weighs in favor of
a speciﬁc picture of the functional Ca21 release unit. This
picture is more complex than one emerging from a study
(Klein et al., 1997), in which partial inactivation of voltage
sensors was used to decimate Ca21 sparks and make them
separable.
In that study the latencies of sparks occurring during
an activating voltage pulse were determined as functions
of pulse voltage, while sparks themselves were found to
be similar at all voltages. A waveform, constructed by
summation of the Ca21 ﬂux time course for each event at its
time of occurrence (i.e., latency), was found to roughly
reproduce main aspects of the macroscopic release record,
speciﬁcally peak and decay to a steady phase. Taken at face
value, this result implies that the properties of release in the
partially inactivated system (time course and voltage
dependence), are representative of the fully primed situation.
Such ‘‘scaling’’ property implies that voltage sensors are in
charge of a cohort of ‘‘slave’’ release channels, constituting
a unit that has in itself all the time- and voltage-dependent
properties of macroscopic release. In particular, such voltage
sensors do not interact. Voltage-dependent inactivation
would just reduce their number, without altering their
properties, including the sparks that they generate with their
cohorts, and the temporal pattern of activation.
By contrast, the present results highlight macroscopic
properties of Ca21 release that are radically altered by
voltage-dependent inactivation, namely the magnitude of its
peak (relative to its steady level) and its dependence on pulse
voltage. It is impossible to explain these results without
assuming some type of interaction among voltage sensors (or
their release channel cohorts), an interaction reduced when
their ranks are thinned by inactivation. Such an interaction of
voltage sensors and their associated release channels was
ﬁrst proposed and simulated quantitatively by Shirokova
et al. (1996).
The effect of the anesthetics used here on the p/s ratio is
similar to that of high intracellular [Mg21] (Kirsch et al.,
1999) or BDM (De Armas et al., 1998), two interventions
known to reduce the Po by direct interaction with ryanodine
receptors. At higher doses, i.e., 0.2 mM tetracaine (Pizarro
et al., 1992, Sa¨rko¨zi et al, 1996), the peak is totally
suppressed. Although this intervention was not used here
to avoid direct block of voltage sensors, it indicates that
the anesthetics are capable of preferentially affecting one
phase—the peak—in support of the dual gating model.
In the present experiments both drugs reduced release ﬂux
during its steady phase. This is in contrast with a study by
Sa¨rko¨zi et al. (1996), who found no effect of tetracaine on
the steady phase\50 mM. Pizarro et al. (1992), who also
reported no effect on this component using 20 mM tetracaine,
limited their study of the steady phase to low test voltages
(Vtest \30 mV). This is in consonance with the results
obtained in the present work for the same voltage range (see
Figs. 3–5). We believe that our observations are consistent
with the notion that CICR contributes to the steady phase of
release. It could also reﬂect an effect of the drugs on channels
gated by voltage.
Tetracaine applied at 0.2 mM totally abolished sparks in
the frog (Shirokova and Rı´os, 1997). Assuming that sparks
largely reﬂect CICR, the result is consistent with the drug
effects reported here, and the interpretation that at lower
concentrations the drugs partially inhibit the Ca21-gated
component. By contrast, treatment with D-600 deferred the
occurrence of sparks and peak generation to more positive
test potentials (Shirokova and Rı´os, 1997). Because D-600
blocks voltage sensors by stabilizing their inactivated state,
its effects are expected to be similar to those of partial
voltage-dependent inactivation, and entirely consistent with
the present results.
Taken together, the results of these studies are best
interpreted as outcomes of selective anesthetic block of one
release component, gated separately by Ca21. The experi-
ments and simulations, however, do not establish to what
extent the drugs also block the putatively voltage-controlled
component. A related issue is whether the Ca21 gated
component is solely responsible for fast, presumably Ca21-
dependent, inactivation (as proposed by Rı´os and Pizarro,
1988). This hypothesis was contradicted by the demonstra-
tion (Jong et al., 1995) that fast inactivation affects both
kinetic components of release ﬂux. It seems therefore
reasonable that both should be sensitive to the anesthetics.
In summary, the radical alteration observed here of
macroscopic Ca21 release kinetics by inactivation of voltage
sensors, is inconsistent with release units separately gated by
individual voltage sensors, requiring instead a degree of
cooperation among sensors. The recovery of Ca21 release
kinetics at high test voltages suggests a secondarily gated
contribution, not directly sensitive to voltage. When dom-
inant, this contribution imbues the macroscopic release with
its characteristic two-phase kinetics. While there are
indications that this component is activated (and inactivated)
by Ca21, the attempt carried out here to speciﬁcally block it
with drugs was inconclusive. Its assignment to a subset of
junctional channels, namely those not in contact with voltage
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sensors, constitutes a seductive possibility, but is based
solely on the general agreement between the results and
simulations with the couplon model. Other possibilities,
including the involvement of parajunctional channels re-
cently described in muscles endowed with two ryanodine
receptor isoforms (Felder and Franzini-Armstrong, 2001),
must be considered as well.
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